← Browse by Condition
Medical Condition
high grade glioma
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, EARLY_Phase 1, Phase 1
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Enrollment
60 pts
Location
United States, Austr...
Sponsor
Rigel Pharmaceuticals
NCT05773326 EARLY_Phase 1
Recruiting
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
Enrollment
12 pts
Location
United States
Sponsor
Nader Sanai
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Enrollment
50 pts
Location
United States
Sponsor
University of California, San ...
NCT06264388 Phase 2
Recruiting
DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment
33 pts
Location
United States
Sponsor
Ashish Shah
NCT07480941 Phase 1
Recruiting
Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
NCT06482905 Phase 1
Recruiting
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
Enrollment
52 pts
Location
United States, China
Sponsor
Tcelltech Inc.
NCT06736470
Recruiting
Surgical Suction Aspirates Fluorescence Measurement
Enrollment
25 pts
Location
Finland
Sponsor
Kuopio University Hospital
NCT05212272
Recruiting
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
Enrollment
16 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT04865315
Recruiting
A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors
Enrollment
50 pts
Location
Netherlands
Sponsor
Maastricht Radiation Oncology